SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
1-Year Return
8.73%
This Quarter Return
-0.45%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$1.44B
AUM Growth
-$16M
(-1.1%)
Cap. Flow
+$44.3M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
85.81%
Holding
128
New
21
Increased
19
Reduced
33
Closed
33
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$143M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$88.2M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$10.3M |
| 4 |
DexCom
DXCM
|
$8.2M |
| 5 |
ResMed
RMD
|
$6.89M |
Top Sells
| 1 |
Simplify MBS ETF
MTBA
|
$55.3M |
| 2 |
Schwab US TIPS ETF
SCHP
|
$38.1M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$25M |
| 4 |
Sarepta Therapeutics
SRPT
|
$19.5M |
| 5 |
Zoetis
ZTS
|
$11.7M |
Sector Composition
| 1 | Healthcare | 11.03% |
| 2 | Energy | 1.63% |
| 3 | Industrials | 1.06% |
| 4 | Consumer Discretionary | 0.54% |
| 5 | Real Estate | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Regeneron Pharmaceuticals
REGN
$60.1B
| $4.46M | 0.22% |
6,258
-3,333
| -35% | -$2.37M |
|
27
Gilead Sciences
GILD
$140B
| $4.26M | 0.21% |
46,167
-50,035
| -52% | -$4.62M |
|
|
BTC
28
Grayscale Bitcoin Mini Trust ETF
BTC
$4.8B
| $4.16M | 0.21% |
99,349
+42,103
| +74% | +$1.76M |
|
|
29
Sarepta Therapeutics
SRPT
$1.93B
| $3.99M | 0.2% |
32,779
-160,231
| -83% | -$19.5M |
|
30
Simplify Multi-QIS Alternative ETF
QIS
$59.3M
| $3.98M | 0.2% |
162,293
+100,258
| +162% | +$2.46M |
|
31
Simplify Managed Futures Strategy ETF
CTA
$1.15B
| $3.92M | 0.19% |
140,378
+86,260
| +159% | +$2.41M |
|
32
Avidity Biosciences
RNA
$6.24B
| $3.64M | 0.18% |
125,000
| – | – |
|
33
Simplify Short Term Treasury Futures Strategy ETF
TUA
$643M
| $3.62M | 0.18% |
170,383
+4,857
| +3% | +$103K |
|
34
Ardelyx
ARDX
$1.58B
| $3.5M | 0.17% |
689,364
| – | – |
|
35
Cigna
CI
$81.2B
| $3.47M | 0.17% |
12,551
-8,382
| -40% | -$2.31M |
|
36
3M
MMM
$82.8B
| $3.34M | 0.17% |
25,871
-13,563
| -34% | -$1.75M |
|
37
Praxis Precision Medicines
PRAX
$970M
| $3.32M | 0.16% |
+43,085
| New | +$3.32M |
|
38
TScan Therapeutics
TCRX
$107M
| $3.18M | 0.16% |
1,046,916
| – | – |
|
39
Establishment Labs
ESTA
$1.12B
| $2.96M | 0.15% |
64,300
+42,661
| +197% | +$1.97M |
|
40
Leap Therapeutics
LPTX
$11.7M
| $2.72M | 0.13% |
946,046
-110,849
| -10% | -$319K |
|
41
Abbott
ABT
$231B
| $2.5M | 0.12% |
22,079
+7,996
| +57% | +$904K |
|
42
Chewy
CHWY
$17B
| $2.46M | 0.12% |
73,411
-110,251
| -60% | -$3.69M |
|
43
Applied Therapeutics
APLT
$67M
| $2.41M | 0.12% |
2,817,505
| – | – |
|
44
Abeona Therapeutics
ABEO
$352M
| $2.28M | 0.11% |
408,584
| – | – |
|
45
Teleflex
TFX
$5.7B
| $2.27M | 0.11% |
12,742
-6,666
| -34% | -$1.19M |
|
46
iShares Core S&P Small-Cap ETF
IJR
$85.7B
| $2.22M | 0.11% |
+19,280
| New | +$2.22M |
|
47
Syndax Pharmaceuticals
SNDX
$1.39B
| $1.95M | 0.1% |
147,641
+25,456
| +21% | +$337K |
|
48
Sanofi
SNY
$111B
| $1.95M | 0.1% |
40,387
-163,756
| -80% | -$7.9M |
|
49
Rithm Capital
RITM
$6.66B
| $1.9M | 0.09% |
175,780
+40,980
| +30% | +$444K |
|
50
Vertex Pharmaceuticals
VRTX
$102B
| $1.89M | 0.09% |
+4,689
| New | +$1.89M |
|